Mitsuhiro Matsuo Selected Research

Mitsuhiro Matsuo Research Topics

Disease

6	Neoplasms (Cancer) 08/2017 - 05/2003
4	Neoplasm Metastasis (Metastasis) 07/2008 - 05/2003
2	Hypertension (High Blood Pressure) 02/2020 - 08/2019
2	Drug Resistant Epilepsy 07/2015 - 07/2012
2	Hepatocellular Carcinoma (Hepatoma) 02/2006 - 06/2003
1	Sleep Wake Disorders 01/2022
1	Chronic Pain 01/2022
1	Pain (Aches) 01/2022
1	Miosis 02/2020
1	Headache (Headaches) 02/2020
1	Tachycardia (Tachyarrhythmias) 02/2020
1	Sarcopenia 06/2019
1	Malnutrition (Nutritional Deficiencies) 06/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2017
1	Dyslipidemias (Dyslipidemia) 08/2017
1	Diabetes Mellitus 08/2017
1	Partial Epilepsies (Epilepsy, Partial) 07/2015
1	Seizures (Absence Seizure) 07/2015
1	Carcinoma (Carcinomatosis) 02/2013
1	Hypersensitivity (Allergy) 01/2012
1	Clinical Deterioration 01/2012
1	Melanoma (Melanoma, Malignant) 07/2008
1	Prostatic Neoplasms (Prostate Cancer) 07/2007
1	Dystonia (Limb Dystonia) 11/2006

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2022 - 06/2003
2	Cholinesterases (Cholinesterase)IBA 02/2020 - 06/2019
2	ErbB Receptors (EGF Receptor)IBA 02/2006 - 06/2003
2	Tyrosine Kinase InhibitorsIBA 02/2006 - 06/2003
2	Gefitinib (Iressa)FDA Link 02/2006 - 06/2003
1	suvorexantIBA 01/2022
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Rivastigmine (Exelon)FDA LinkGeneric 02/2020
1	Cholinergic Agents (Cholinergics)IBA 02/2020
1	distigmine (distigmine bromide)IBA 02/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2017
1	Clopidogrel (Plavix)FDA Link 08/2017
1	Levetiracetam (Keppra)FDA LinkGeneric 07/2015
1	MicroRNAs (MicroRNA)IBA 02/2013
1	Biological ProductsIBA 02/2013
1	Topiramate (Topamax)FDA LinkGeneric 07/2012
1	Ketamine FDA LinkGeneric 01/2012
1	Prednisolone (Predate)FDA LinkGeneric 01/2012
1	Midazolam (Versed)FDA LinkGeneric 01/2012
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2012
1	Neuregulin-1 (Neuregulin 1)IBA 07/2008
1	LigandsIBA 07/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2008
1	histidine-rich proteinsIBA 07/2008
1	AntibodiesIBA 07/2007
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2007
1	BerberineIBA 06/2007
1	CurcuminIBA 06/2007
1	Guanosine Triphosphate (GTP)IBA 11/2006
1	Fibronectins (Fibronectin)IBA 02/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2006
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2006
1	Integrin alphaVIBA 02/2006
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2003
1	Peptide Hydrolases (Proteases)FDA Link 05/2003
1	Matrix Metalloproteinases (MMPs)IBA 05/2003
1	N- hydroxy- 5- ethoxymethyloxy- 2- methyl- 4- (4- phenoxybenzoyl)aminopentanamideIBA 05/2003
1	Messenger RNA (mRNA)IBA 05/2003

Therapy/Procedure

2	Therapeutics 08/2019 - 07/2015
1	Ligation 01/2022